Association of Common Variation in the HNF1α Gene Region With Risk of Type 2 Diabetes

  1. Wendy Winckler123,
  2. Noël P. Burtt3,
  3. Johan Holmkvist4,
  4. Camilla Cervin4,
  5. Paul I.W. de Bakker123,
  6. Maria Sun13,
  7. Peter Almgren4,
  8. Tiinamaija Tuomi5,
  9. Daniel Gaudet6,
  10. Thomas J. Hudson7,
  11. Kristin G. Ardlie8,
  12. Mark J. Daly3,
  13. Joel N. Hirschhorn239,
  14. David Altshuler1231011 and
  15. Leif Groop45
  1. 1Department of Molecular Biology, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts
  2. 2Department of Genetics, Harvard Medical School, Boston, Massachusetts
  3. 3Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts
  4. 4Department of Endocrinology, University Hospital MAS, Lund University, Malmö, Sweden
  5. 5Department of Medicine, Helsinki University Central Hospital, Folkhalsan Genetic Institute, Folkhalsan Research Center, and Research Program for Molecular Medicine, University of Helsinki, Helsinki, Finland
  6. 6University of Montreal Community Genomic Center, Chicoutimi Hospital, Montreal, Quebec, Canada
  7. 7McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada
  8. 8Genomics Collaborative, Inc., Cambridge, Massachusetts
  9. 9Divisions of Genetics and Endocrinology, Children’s Hospital, Boston, Massachusetts
  10. 10Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts
  11. 11Department of Medicine, Harvard Medical School, Boston, Massachusetts
  1. Address correspondence and reprint requests to David Altshuler, Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114. E-mail: altshuler{at}molbio.mgh.harvard.edu. Or Leif Groop, Department of Endocrinology, University Hospital MAS, Lund University, Malmö, Sweden. E-mail: leif.groop{at}endo.mas.lu.se

Abstract

It is currently unclear how often genes that are mutated to cause rare, early-onset monogenic forms of disease also harbor common variants that contribute to the more typical polygenic form of each disease. The gene for MODY3 diabetes, HNF1α, lies in a region that has shown linkage to late-onset type 2 diabetes (12q24, NIDDM2), and previous association studies have suggested a weak trend toward association for common missense variants in HNF1α with glucose-related traits. Based on genotyping of 79 common SNPs in the 118 kb spanning HNF1α, we selected 21 haplotype tag single nucleotide polymorphisms (SNPs) and genotyped them in >4,000 diabetic patients and control subjects from Sweden, Finland, and Canada. Several SNPs from the coding region and 5′ of the gene demonstrated nominal association with type 2 diabetes, with the most significant marker (rs1920792) having an odds ratio of 1.17 and a P value of 0.002. We then genotyped three SNPs with the strongest evidence for association to type 2 diabetes (rs1920792, I27L, and A98V) in an additional 4,400 type 2 diabetic and control subjects from North America and Poland and compared our results with those of the original sample and of Weedon et al. None of the results were consistently observed across all samples, with the possible exception of a modest association of the rare (3–5%) A98V variant. These results indicate that common variants in HNF1α either play no role in type 2 diabetes, a very small role, or a role that cannot be consistently observed without consideration of as yet unmeasured genetic or environmental modifiers.

Footnotes

  • D.A. and L.G. jointly supervised this project.

    J.N.H. has received consulting fees from Correlagen. D.A. has served on advisory panels for and received consulting fees from Genomics Collaborative, Inc. L.G. has served on advisory panels for and received consulting fees from Aventis-Sanofi, Bristol-Myers Squibb, Kowa, and Roche.

    • Accepted February 16, 2005.
    • Received November 24, 2004.
« Previous | Next Article »Table of Contents